Back to Search
Start Over
Evolving management of patients treated by drug-eluting stent: Prevention of late events.
- Source :
-
Cardiovascular Revascularization Medicine . Mar2014, Vol. 15 Issue 2, p100-108. 9p. - Publication Year :
- 2014
-
Abstract
- Abstract: Summary: Drug eluting stents (DES) were introduced in clinical practice to overcome the problem of in-stent restenosis (ISR) that limited the overall efficacy of percutaneous coronary revascularization with bare metal stent (BMS). Long-term outcome data confirm a sustained benefit of DES as compared with BMS. However, this benefit is mainly evident in the first year of follow-up. Indeed, DES-related events may extend over this time, due to late events (late ISR and/or very late stent thrombosis). Prevention of late failure of DES may become a specific therapeutic target. [Copyright &y& Elsevier]
Details
- Language :
- English
- ISSN :
- 15538389
- Volume :
- 15
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Cardiovascular Revascularization Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 95384385
- Full Text :
- https://doi.org/10.1016/j.carrev.2014.01.012